Immunohistochemical analysis of vascular endothelial growth factor (VEGF) and p53 expression in pterygium from Tunisian patients

Pathologie Biologie

Volumn 59, Issue 3, 2011, Pages 137-141

  Khalfaoui, T ^a   Mkannez, G ^a   Colin, D ^b   Imen, A ^a   Zbiba, W ^a   Errais, K ^a   Anane, R ^a   Beltaief, O ^a   Zhioua, R ^a   Ben Hamida, J ^c   Lizard, G ^b   Ouertani Meddeb, A ^a  

^a CHARLES NICOLLE HOSPITAL   (Tunisia)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

Author keywords

Conjunctiva; Neovascularization; P53; Pterygium; VEGF

Indexed keywords

POLYCLONAL ANTIBODY; PROTEIN P53; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIUM CELL; FEMALE; FIBROBLAST; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PTERYGIUM; TUNISIA; VASCULAR ENDOTHELIUM;

EID: 79958736377     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2009.04.006     Document Type: Article

References (26)

1. Deitch R.D., Wilson F.M. Management of pterygia. Principles and practice of ophthalmic plastic and reconstructive surgery 1996, 206-221. Saunders WB, USA. S. Bosniak (Ed.).
2. Cornand J. Ptérygion. J Fr Ophtalmol 1990, 13:33-45.
3. Kria L., Amemiya T., Dake Y., Omar B., Ouertani A.M. Pterygium with bulbar conjunctival hemorrhages. Graefes Arch Clin Exp Ophthalmol 1999, 237:468-473.
4. Kria L., Ohira A. Growth factors in cultured pterygium fibroblasts: immunohistochemical, ELISA analysis. Graefes Arch Clin Exp Ophthalmol 1998, 236:702-708.
5. Kria L., Ohira A., Amemiya T. TNP-470 (a fungus-derived inhibitor of angiogenesis) reduces proliferation of cultured fibroblasts isolated from primary pterygia: a possible drug therapy for pterygia. Curr Eye Res 1998, 17:986-993.
6. Quart E. VEGF and tumor angiogenesis. J Biol Med 2001, 18:59-66.
7. Aiello L.P. Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications of therapies. Ophthalmic Res 1997, 29:354-362.
8. Casey R. Factors controlling angiogenesis. Am J Ophthalmol 1997, 124:521-529.
9. Sarioglu S., Sokmen S., Terzi C., Ozer E., Füzun M. Relationship of angiogenesis and p53 protein expression in colorectal carcinomas. Colorectal Dis 2001, 3:38-41.
10. Bargonetti J., Manfredi J.J. Multiple roles of the tumor suppressor p53. Curr Opin Oncol 2002, 14:86-91.
11. Dushku N., Reid T.W. P53 expression in altered limbal basal cells of pinguecula, pterygia and limbal tumors. Curr Eye Res 1997, 16:1179-1192.
12. Chowers I., Folberg R. p53 immunoreactivity, Ki-67 expression and microcirculation patterns in melanoma of the iris, ciliary body and choroid. Curr Eye Res 2002, 24:105-108.
13. Sangwan V.S., Merchant A., Sainz de la Maza M., Foster C.S. Leucocyte adhesion molecule expression in scleritis. Arch Ophthalmol 1998, 116:1476-1480.
14. Lutty G.A., McLeod D.S., Merges C., Diggs A., Plouet J. Localization of vascular endothelial growth factor in human retina and choroid. Arch ophthalmol 1996, 114:971-977.
15. Kim I., Ryan A.M., Rohan R., et al. Constitutive expression of VEGF, VEGFR-1, VEGFR-2 in normal eyes. Invest Ophthalmol Vis Sci 1999, 40:2115-2121.
16. Lee D.H., Cho H.J., Kim J.T., Choi J.S., Joo C.K. Expression of vascular endothelial growth and inducible nitric oxide synthetase in pterygia. Cornea 2001, 20:738-742.
17. Marcovich A.L., Morad Y., Sandbank J., et al. Angiogenesis in pterygium: morphometric and immunohistochemical study. Curr Eye Res 2002, 25:17-22.
18. Van Setten G., Aspiotis M., Blalock T.D. Connective tissue growth factor in pterygium: simultaneous presence with vascular endothelial growth factor - possible contributing factor to conjunctival scarring. Graefes Arch Clin Exp Ophthalmol 2003, 241:135-139.
19. Tan D.T., Lim A.S., Goh H.S., Smith D.R. Abnormal expression of p53 tumor suppressor gene in the conjunctiva of patients with pterygium. Am J Ophthalmol 1997, 123:404-405.
20. Chowers I., Pe'er J., Zamir E., Livni N., Ilsar M., Frucht-Pery J. Proliferative activity and p53 expression in primary and recurrent pterygia. Ophthalmology 2001, 108:985-988.
21. Weinstein O., Rosenthal G., Zirkin H., Monos T., Lifshitz T., Argov S. Overexpression of p53 tumor suppressor gene in pterygia. Eye 2002, 1:619-621.
22. Onur C., Orhan D., Orhan M., Dizbay-Sak S., Tulunay O., Irkeç M. Expression of p53 protein in pterygia. Eur J Ophthalmol 1998, 8:157-161.
23. Ueda Y., Kanazawa S., Kitaoka T., et al. Immunohistochemical study of p53, p21 and PCNA in pterygium. Acta Histochem 2001, 103:159-165.
24. Nagano T., Ueda M., Ichihashi M. Expression of p53 protein is an early event in ultraviolet light-induced cutaneous squamous cell carcinogenesis. Arch Ophthalmol 1994, 129:1157-1161.
25. Rosa A.R., Schirmer C.C., Gurski R.R., Meurer L., Edelweiss M.I., Kruel C.D. Prognostic value of p53 protein expression and vascular endothelial growth factor expression in resected squamous cell carcinoma of the oesophagus. Dis Esophagus 2003, 16:112-118.
26. Kieser A., Weich H.A., Brandner G., Marmé D., Kolch W. Mutant p53 potentiates protein kinase C induction of VEGF. Oncogene 1994, 9:963-969.